Haemonetics Corporation HAE
NYSE
| 06/27/2026 | 03/28/2026 | 12/27/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.00% | -134.75% | 19.33% | 14.34% | -11.32% |
| Total Depreciation and Amortization | -5.73% | -1.34% | -5.65% | -3.29% | -1.30% |
| Total Amortization of Deferred Charges | -- | -8.96% | -- | -- | -- |
| Total Other Non-Cash Items | 21.00% | 848.05% | -23.38% | 39.22% | 163.24% |
| Change in Net Operating Assets | 63.95% | -115.29% | 133.43% | 195.34% | 29.75% |
| Cash from Operations | 200.79% | -39.14% | 113.78% | 128.01% | 163.44% |
| Capital Expenditure | -110.60% | -12.90% | 25.71% | 46.82% | 33.63% |
| Sale of Property, Plant, and Equipment | -20.20% | -78.54% | 72.11% | -36.51% | -98.54% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.70% | 22.90% | -159.46% | -106.76% | -521.70% |
| Cash from Investing | 32.62% | -580.12% | -69.63% | -30.39% | 76.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,198.98% | -19,193.79% | -0.06% | -- | 99.69% |
| Issuance of Common Stock | -9.88% | -12.86% | 6.50% | -74.90% | -10.54% |
| Repurchase of Common Stock | 26.79% | 33.30% | 64.37% | 0.04% | 50.96% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 61.11% | 51.85% | 90.60% | -254.55% | 99.97% |
| Cash from Financing | -2,010.07% | 32.98% | 47.32% | -2.34% | -100.73% |
| Foreign Exchange rate Adjustments | -114.75% | -127.29% | 113.04% | -118.40% | 389.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.08% | -737.37% | 210.44% | 107.81% | -108.37% |